| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/08/2006 | US20060122113 Mixtures of polypeptides, compositions containing and processes for preparing same, and uses thereof |
| 06/08/2006 | US20060122111 Regeneration and neogenesis of retinal visual cell otx2 gene |
| 06/08/2006 | US20060122106 Prevention and/or treatment of inflammatory bowel disease using pyy or agonists thereof |
| 06/08/2006 | US20060122105 Method of improing the growth performance of an animal |
| 06/08/2006 | US20060122103 Dalfopristine/quinupristine combinations with cefpirome |
| 06/08/2006 | US20060122100 Melanin extinguisher |
| 06/08/2006 | US20060122097 Uptake of macromolecules |
| 06/08/2006 | US20060122095 Mucus formulation for mucosal surfaces and uses thereof |
| 06/08/2006 | US20060121583 New method for synthesizing ceramide-type compounds |
| 06/08/2006 | US20060121550 Modulation of PDE11A activity |
| 06/08/2006 | US20060121545 Rapamycin conjugates and antibodies |
| 06/08/2006 | US20060121526 Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression |
| 06/08/2006 | US20060121488 Glutamate transport modulatory compounds and methods |
| 06/08/2006 | US20060121465 Sgk and nedd used as diagnostic and therapeutic targets |
| 06/08/2006 | US20060121454 diagnosis and treatment of carcinomas, especially breast cancers |
| 06/08/2006 | US20060121453 Pre-incubation assay methods |
| 06/08/2006 | US20060121449 Method for selection of compounds which inhibit clonal cell growth and use thereof |
| 06/08/2006 | US20060121180 Using electrochemical solution containing metal compound and bioactive materials; contacting substrate |
| 06/08/2006 | US20060121138 Hepatocurative effect of Emblica officinalis against CYP 450 bio-activation hepatotoxicity of drugs |
| 06/08/2006 | US20060121136 Hypotensive agent and method for producing same |
| 06/08/2006 | US20060121135 Use of extracts of Ginkgo biloba for preparing a medicament intended to treat sarcopenia |
| 06/08/2006 | US20060121133 Antioxidant dietary supplement compositions and methods for maintaining healthy skin |
| 06/08/2006 | US20060121132 TNF-alpha production inhibitor comprising kavalactone as an active ingredient |
| 06/08/2006 | US20060121131 Pharmaceutical compositions comprising cereal beta (1-3) beta (1-4) glucan |
| 06/08/2006 | US20060121129 Dietary supplement |
| 06/08/2006 | US20060121128 Increasing cytosolic calcium levels in airway epithelial cell by contacting purinergic (P2X) receptors on cell with zinc chloride; cystic fibrosis, asthma, allergies, polycystic kidney disease and salt-sensitive hypertension syndromes, diabetes; drug screening; nasal spray |
| 06/08/2006 | US20060121127 Stabilized lanthanum carbonate compositions |
| 06/08/2006 | US20060121125 Formulation which can be administered gastrointestinally, containing green tea extract and an no donor |
| 06/08/2006 | US20060121119 Process for producing nanoparticles of paclitaxel and albumin |
| 06/08/2006 | US20060121118 Antimycotic gel having high active compound release |
| 06/08/2006 | US20060121117 Anti-angiogenic compositions and methods of use |
| 06/08/2006 | US20060121114 Method of manufacturing sustained release microbeads containing venlafaxine HCL |
| 06/08/2006 | US20060121113 Pharmaceutical composition containing 6-dimethylaminomethyl-1-(3-methoxyphenyl)-cyclohexane-1,3-diol with delayed active ingredient release |
| 06/08/2006 | US20060121112 Topiramate pharmaceutical composition |
| 06/08/2006 | US20060121111 Formulations of substituted benzoxazoles |
| 06/08/2006 | US20060121110 Formulations of substituted benzoxazoles |
| 06/08/2006 | US20060121109 Formulations of substituted benzoxazoles |
| 06/08/2006 | US20060121108 System and method for producing a directly compressible, high-potency formulation of metformin hydrochloride |
| 06/08/2006 | US20060121107 Agent improving proton-driven transporter-mediated absorption in digestive tract and process for producing the same |
| 06/08/2006 | US20060121106 Therapeutic system comprising amoxicillin and clavulanic acid |
| 06/08/2006 | US20060121102 Transdermal systems for the delivery of estrogens and progestins |
| 06/08/2006 | US20060121094 Preparation comprising 1,3 and/or 1,6 beta glucans for the treatment of infections and inflammations in animals |
| 06/08/2006 | US20060121091 Cellular uptake of bioactive agents |
| 06/08/2006 | US20060121090 Ocular compositions that increases the activity of gelatinase a in ocular cells |
| 06/08/2006 | US20060121089 Coatings for implantable medical devices |
| 06/08/2006 | US20060121088 delivering to an external portion of the body passageway a therapeutic agent such as an antiangiogenic factor from a thread; treating stenosis or restenosis for example |
| 06/08/2006 | US20060121086 Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound |
| 06/08/2006 | US20060121085 Formulations for cell-schedule dependent anticancer agents |
| 06/08/2006 | US20060121083 Anti-microbial medical implants and uses thereof |
| 06/08/2006 | US20060121072 Topical parasiticide formulations and methods of treatment |
| 06/08/2006 | US20060121071 Stable hydroalcoholic compositions |
| 06/08/2006 | US20060121069 Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins |
| 06/08/2006 | US20060121067 Menthol-containing preparation |
| 06/08/2006 | US20060121066 Sucralose formulations to mask unpleasant tastes |
| 06/08/2006 | US20060121059 Vaccine composition |
| 06/08/2006 | US20060121058 Anti-pneumococcal preparations |
| 06/08/2006 | US20060121055 Compositions with enhanced immunogenicity |
| 06/08/2006 | US20060121047 Use of hmgb polypetides for increasing immune responses |
| 06/08/2006 | US20060121041 Gpcs as modifiers of the irrtk p21 pathways and methods of use |
| 06/08/2006 | US20060121040 Compositions and methods for treating neuroendocrine tumors |
| 06/08/2006 | US20060121039 Use of agents that prevent the generation of amyloid-like proteins and/or drusen, and/or use of agents that promote sequestration and/or degradation of, and/or prevent the neurotoxic effects of such proteins in the treatment of macular degeneration |
| 06/08/2006 | US20060121035 Methods for treating diabetes |
| 06/08/2006 | US20060121034 Treatment for alzheimer's disease and related conditions |
| 06/08/2006 | US20060121033 Using antibodies which bind specifically to DC-SIGN; Agents that bind to ICAM-3 are used to block inhibition of activation of macrophages by DC-SIGN-ICAM-3 interaction and cause inhibition of rheumatoid arthritis symptoms |
| 06/08/2006 | US20060121025 VEGF-related protein |
| 06/08/2006 | US20060121024 Novel class of sterol ligands and their uses in regulation of cholesterol and gene expression |
| 06/08/2006 | US20060121019 Compositions for treating cystic fibrosis |
| 06/08/2006 | US20060121016 Methods and compositions for treatment of free radical injury |
| 06/08/2006 | US20060121013 Use of negative regulatory elements for the neurospecific expression of transgenes |
| 06/08/2006 | US20060121010 Chorionic gonadotropin DNA vaccines and methods |
| 06/08/2006 | US20060121003 In situ maturation of dendritic cells |
| 06/08/2006 | US20060120996 Vaccine immunotherapy for immune suppressed patients |
| 06/08/2006 | US20060120994 Bioabsorbable polymers |
| 06/08/2006 | US20060120993 Treatment of lesions of the soft tissues |
| 06/08/2006 | US20060120992 Rapid dehydration of proteins |
| 06/08/2006 | US20060120991 N-halamine vinyl compounds and their polymeric biocides |
| 06/08/2006 | US20060120988 Hair treatment compositions |
| 06/08/2006 | US20060120978 Dihydroxyphenyl compounds and glucoside compounds thereof |
| 06/08/2006 | US20060120977 Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues |
| 06/08/2006 | US20060120976 Dermatological compositions and methods |
| 06/08/2006 | US20060120974 Nicotine delivery systems |
| 06/08/2006 | US20060120973 powders containing human growth hormone; for treatment or prevention of growth retardation, growth hormone deficiency, or for control of HIV-related wasting and cachexia |
| 06/08/2006 | US20060120972 9-(N-methyl-piperidyliden-4)-thioxanthene for treatment of pulmonary hypertension |
| 06/08/2006 | US20060120971 Agents and methods for administration to the central nervous system |
| 06/08/2006 | US20060120970 exposing a lactose mixture which does not exclusively contain alpha-lactose-monohydrate to a relative humidity of at least 85% to provide a lactose which contains exclusively alpha-lactose-monohydrate having a desorption heat of less than 40 J/g.; surface-energy passivation of lactose |
| 06/08/2006 | US20060120967 Solution forms of cyclodextrins for nasal or throat delivery of essential oils |
| 06/08/2006 | US20060120966 Salmeterol superfine formulation |
| 06/08/2006 | US20060118003 Light-blocking agent and film-forming composition |
| 06/08/2006 | DE20122582U1 Zubereitung für Restenoseprophylaxe Preparation for prophylaxis of restenosis |
| 06/08/2006 | DE20023815U1 Azithromycin enthaltende Zusammensetzungen Azithromycin-containing compositions |
| 06/08/2006 | DE19781792B4 6,7-Disubstituierte 8-Methyl-4-oxo-4H-1-benzopyran-5-carbonsäuren, Fermentationsverfahren zu deren Herstellung und diese Verbindungen enthaltende therapeutische Zusammensetzung 6,7-Disubstituted-8-methyl-4-oxo-4H-1-benzopyran-5-carboxylic acids, to their preparation and therapeutic composition containing compounds fermentation process |
| 06/08/2006 | DE102004058079A1 Steigerung des Proteinanteils tierischer Organismen Increase in the protein fraction of animal organisms |
| 06/08/2006 | DE102004058062A1 Cyclische Iminocarbamate und ihre Verwendung Cyclic Iminocarbamate and their use |
| 06/08/2006 | DE102004057595A1 Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen Substituted pteridines for the treatment of inflammatory diseases |
| 06/08/2006 | DE102004057594A1 Substitueirte Pteridine zur Behandlung von entzündlichen Erkrankungen Substitueirte pteridines for the treatment of inflammatory diseases |
| 06/08/2006 | DE102004056822A1 Neue Wirkstoffe zu Therapie, Diagnostik und Prophylaxe der Makula-Degeneration New drugs for the therapy, diagnosis and prevention of macular degeneration |
| 06/08/2006 | DE102004055932A1 Zubereitung enthaltend oxidierte Flavonoid-Derivate Preparation containing oxidized flavonoid derivatives |
| 06/08/2006 | CA2738383A1 Bicyclic amides as kinase inhibitors |
| 06/08/2006 | CA2610347A1 Alpha-carbolines as cdk-1 inhibitors |
| 06/08/2006 | CA2590720A1 Heteroaromatic glucokinase activators |